Mortierella vinacea
Species
KNApSAcK Entry
| Organism name | Mortierella vinacea |
|---|---|
| Genus | Mortierella |
| Family | Mortierellaceae |
| Kingdom | Fungi |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Umbelopsis vinacea |
|---|---|
| Linked NCBI taxonomy ID | 44442 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Umbelopsidaceae |
|---|---|
| ID | 1403793 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Fungi |
|---|---|
| ID | 4751 |
Plant class
| Plant class | |
|---|---|
| ID |
Metabolite list (5)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00049391
|
Methyl 2,4-dihydroxy-3,5,6-trimethylbenzoate
|
CHEMBL507391
|
No. 3641 |
|
||||
|
C00000208
|
Nicotinic acid
|
CHEMBL573
CHEMBL2074803 |
D009525
|
100 / 38 / 34 | 48 / 110 | No. 3681 | No. 1 |
|
|
C00028600
|
Mortivinacin B
|
CHEMBL508919
|
No. 5265 |
|
||||
|
C00028601
|
Mortivinacin C
|
CHEMBL453010
|
No. 5265 |
|
||||
|
C00028599
|
Mortivinacin A
|
CHEMBL454052
|
No. 5474 |
|
Human Protein / Gene in interactions
100 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000208 | 1 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000208 | 0 / 0 |
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000208 | 0 / 0 |
| Q96FL8 | Multidrug and toxin extrusion protein 1 | Cation antiporter | C00000208 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000208 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000208 | 0 / 3 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000208 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00000208 | 2 / 1 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000208 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000208 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000208 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000208 | 1 / 1 |
| P29466 | Caspase-1 | C14 | C00000208 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00000208 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000208 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000208 | 2 / 2 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000208 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000208 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000208 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00000208 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00000208 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000208 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000208 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000208 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000208 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000208 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000208 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000208 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000208 | 0 / 1 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000208 | 1 / 8 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000208 | 2 / 0 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000208 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000208 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000208 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000208 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000208 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000208 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000208 | 1 / 1 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000208 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000208 | 1 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000208 | 0 / 0 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000208 | 0 / 0 |
| Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
| Q9BXC0 | Hydroxycarboxylic acid receptor 1 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000208 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000208 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000208 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000208 | 0 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000208 | 1 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000208 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00000208 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000208 | 0 / 0 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000208 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000208 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000208 | 1 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000208 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00000208 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000208 | 1 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000208 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000208 | 0 / 1 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000208 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000208 | 0 / 1 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000208 | 2 / 0 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000208 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000208 | 0 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000208 | 2 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000208 | 5 / 9 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000208 | 1 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00000208 | 0 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000208 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000208 | 3 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000208 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000208 | 1 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000208 | 0 / 0 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000208 | 2 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000208 | 0 / 0 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000208 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000208 | 1 / 1 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000208 | 1 / 0 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000208 | 1 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000208 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000208 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000208 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000208 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00000208 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000208 | 0 / 0 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000208 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000208 | 1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000208 | 0 / 1 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000208 | 0 / 0 |
| P49019 | Hydroxycarboxylic acid receptor 3 | Hydroxycarboxylic acid receptor | C00000208 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00000208 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000208 | 1 / 1 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000208 | 0 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000208 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000208 | 0 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000208 | 1 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000208 | 0 / 1 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000208 | 0 / 0 |
| O76082 | Solute carrier family 22 member 5 | Unclassified protein | C00000208 | 1 / 2 |
48 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00000208
|
| 9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00000208
|
| 183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00000208
|
| 197 | AHSG, A2HS, AHS, FETUA, HSGA | alpha-2-HS-glycoprotein |
C00000208
|
| 335 | APOA1 | apolipoprotein A-I |
C00000208
|
| 338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00000208
|
| 506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00000208
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000208
|
| 1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00000208
|
| 1052 | CEBPD, C/EBP-delta, CELF, CRP3, NF-IL6-beta | CCAAT/enhancer binding protein (C/EBP), delta |
C00000208
|
| 1376 | CPT2, CPT1, CPTASE, IIAE4 | carnitine palmitoyltransferase 2 (EC:2.3.1.21) |
C00000208
|
| 1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00000208
|
| 84649 | DGAT2, ARAT, GS1999FULL | diacylglycerol O-acyltransferase 2 (EC:2.3.1.20 2.3.1.76) |
C00000208
|
| 2149 | F2R, CF2R, HTR, PAR-1, PAR1, TR | coagulation factor II (thrombin) receptor |
C00000208
|
| 2194 | FASN, FAS, OA-519, SDR27X1 | fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) |
C00000208
|
| 2641 | GCG, GLP1, GLP2, GRPP | glucagon |
C00000208
|
| 2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00000208
|
| 338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00000208
|
| 8843 | HCAR3, GPR109B, HCA3, HM74, PUMAG, Puma-g | hydroxycarboxylic acid receptor 3 |
C00000208
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000208
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00000208
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000208
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00000208
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000208
|
| 3952 | LEP, LEPD, OB, OBS | leptin |
C00000208
|
| 3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00000208
|
| 4018 | LPA, AK38, APOA, LP | lipoprotein, Lp(a) (EC:3.4.21.-) |
C00000208
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000208
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000208
|
| 10062 | NR1H3, LXR-a, LXRA, RLD-1 | nuclear receptor subfamily 1, group H, member 3 |
C00000208
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00000208
|
| 5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00000208
|
| 7941 | PLA2G7, LDL-PLA2, LP-PLA2, PAFAD, PAFAH | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47) |
C00000208
|
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00000208
|
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000208
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00000208
|
| 5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00000208
|
| 5729 | PTGDR, AS1, ASRT1, DP, DP1, PTGDR1 | prostaglandin D2 receptor (DP) |
C00000208
|
| 5730 | PTGDS, L-PGDS, LPGDS, PDS, PGD2, PGDS, PGDS2 | prostaglandin D2 synthase 21kDa (brain) (EC:5.3.99.2) |
C00000208
|
| 5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000208
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000208
|
| 56729 | RETN, ADSF, FIZZ3, RETN1, RSTN, XCP1 | resistin |
C00000208
|
| 949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000208
|
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00000208
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00000208
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000208
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000208
|
| 7448 | VTN, V75, VN, VNT | vitronectin |
C00000208
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (38)
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| #300615 | Brunner syndrome |
P21397
|
| #212140 | Carnitine deficiency, systemic primary; cdsp |
O76082
|
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #137800 | Glioma susceptibility 1; glm1 |
P04626
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
|
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #112100 | Yt blood group antigen |
P22303
|
KEGG DISEASE (34)
| KEGG | name | UniProt |
|---|---|---|
| H00286 | Crohn's disease |
O76082
(related)
|
| H00525 | Disorders of fatty-acid oxidation |
O76082
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
|
| H00027 | Ovarian cancer |
P04626
(related)
|
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
Diseases related to CTD interactions
110 disease in interactions with metabolites
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D000138 | Acidosis |
C00000208
|
| D000140 | Acidosis, Lactic |
C00000208
|
| D000544 | Alzheimer Disease |
C00000208
|
| D000550 | Amblyopia |
C00000208
|
| D000749 | Anemia, Megaloblastic |
C00000208
|
| D001161 | Arteriosclerosis |
C00000208
|
| D050197 | Atherosclerosis |
C00000208
|
| D001943 | Breast Neoplasms |
C00000208
|
| D002318 | Cardiovascular Diseases |
C00000208
|
| D002340 | Carotid Artery Diseases |
C00000208
|
| D002386 | Cataract |
C00000208
|
| D002418 | Cattle Diseases |
C00000208
|
| D023341 | Chills |
C00000208
|
| D002779 | Cholestasis |
C00000208
|
| D002780 | Cholestasis, Intrahepatic |
C00000208
|
| D043171 | Chromosomal Instability |
C00000208
|
| D002971 | Cleft Lip |
C00000208
|
| D002972 | Cleft Palate |
C00000208
|
| D003072 | Cognition Disorders |
C00000208
|
| D003324 | Coronary Artery Disease |
C00000208
|
| D003327 | Coronary Disease |
C00000208
|
| D023921 | Coronary Stenosis |
C00000208
|
| D003693 | Delirium |
C00000208
|
| D003920 | Diabetes Mellitus |
C00000208
|
| D003925 | Diabetic Angiopathies |
C00000208
|
| D004244 | Dizziness |
C00000208
|
| D056486 | Drug-Induced Liver Injury |
C00000208
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000208
|
| D020820 | Dyskinesias |
C00000208
|
| D050171 | Dyslipidemias |
C00000208
|
| D004415 | Dyspepsia |
C00000208
|
| D004487 | Edema |
C00000208
|
| D019446 | Endotoxemia |
C00000208
|
| D004890 | Erythema |
C00000208
|
| D005076 | Exanthema |
C00000208
|
| D005094 | Exophthalmos |
C00000208
|
| D005128 | Eye Diseases |
C00000208
|
| D005141 | Eyelid Diseases |
C00000208
|
| D005234 | Fatty Liver |
C00000208
|
| D005483 | Flushing |
C00000208
|
| D005767 | Gastrointestinal Diseases |
C00000208
|
| D005923 | Glomerulosclerosis, Focal Segmental |
C00000208
|
| D018149 | Glucose Intolerance |
C00000208
|
| D006073 | Gout |
C00000208
|
| D006501 | Hepatic Encephalopathy |
C00000208
|
| D006505 | Hepatitis |
C00000208
|
| D006937 | Hypercholesterolemia |
C00000208
|
| D006943 | Hyperglycemia |
C00000208
|
| D020138 | HYPERHOMOCYSTEINEMIA |
C00000208
|
| D006950 | Hyperlipidemia, Familial Combined |
C00000208
|
| D006949 | Hyperlipidemias |
C00000208
|
| D006951 | Hyperlipoproteinemias |
C00000208
|
| D006938 | Hyperlipoproteinemia Type II |
C00000208
|
| D006952 | Hyperlipoproteinemia Type III |
C00000208
|
| D006954 | Hyperlipoproteinemia Type V |
C00000208
|
| D006973 | Hypertension |
C00000208
|
| D015228 | Hypertriglyceridemia |
C00000208
|
| D052456 | Hypoalphalipoproteinemias |
C00000208
|
| D007003 | Hypoglycemia |
C00000208
|
| D018476 | Hypokinesia |
C00000208
|
| D007009 | Hypolipoproteinemias |
C00000208
|
| D007022 | Hypotension |
C00000208
|
| D020244 | Infarction, Middle Cerebral Artery |
C00000208
|
| D007249 | Inflammation |
C00000208
|
| D007333 | Insulin Resistance |
C00000208
|
| D002546 | Ischemic Attack, Transient |
C00000208
|
| D007565 | Jaundice |
C00000208
|
| D007634 | Keratitis |
C00000208
|
| D007662 | Ketosis |
C00000208
|
| D007676 | Kidney Failure, Chronic |
C00000208
|
| D007938 | Leukemia |
C00000208
|
| D015470 | Leukemia, Myeloid, Acute |
C00000208
|
| D008060 | Lipodystrophy |
C00000208
|
| D017114 | Liver Failure, Acute |
C00000208
|
| D055370 | Lung Injury |
C00000208
|
| D008269 | Macular Edema |
C00000208
|
| D047508 | Massive Hepatic Necrosis |
C00000208
|
| D024821 | Metabolic Syndrome X |
C00000208
|
| D008881 | Migraine Disorders |
C00000208
|
| D009127 | Muscle Rigidity |
C00000208
|
| D009135 | Muscular Diseases |
C00000208
|
| D009203 | Myocardial Infarction |
C00000208
|
| D017202 | Myocardial Ischemia |
C00000208
|
| D015428 | Myocardial Reperfusion Injury |
C00000208
|
| D009325 | Nausea |
C00000208
|
| D009336 | Necrosis |
C00000208
|
| D009369 | Neoplasms |
C00000208
|
| D009798 | Ocular Hypertension |
C00000208
|
| D010146 | Pain |
C00000208
|
| D010292 | Paresthesia |
C00000208
|
| D010383 | Pellagra |
C00000208
|
| D010523 | Peripheral Nervous System Diseases |
C00000208
|
| D010612 | Pharyngitis |
C00000208
|
| D011014 | Pneumonia |
C00000208
|
| D011507 | Proteinuria |
C00000208
|
| D011537 | Pruritus |
C00000208
|
| D012162 | Retinal Degeneration |
C00000208
|
| D012164 | Retinal Diseases |
C00000208
|
| D012817 | Signs and Symptoms, Digestive |
C00000208
|
| D012859 | Sjogren's Syndrome |
C00000208
|
| D012871 | Skin Diseases |
C00000208
|
| D012877 | Skin Manifestations |
C00000208
|
| D016135 | Spinal Dysraphism |
C00000208
|
| D020521 | Stroke |
C00000208
|
| D013575 | Syncope |
C00000208
|
| D018781 | Tension-Type Headache |
C00000208
|
| D014098 | Toothache |
C00000208
|
| D014786 | Vision Disorders |
C00000208
|
| D014839 | Vomiting |
C00000208
|
| D014947 | Wounds and Injuries |
C00000208
|